Table 3.
Relative risk of sarcopenia was calculated according to NLR or PLR levels a .
| Characteristic | N | Basic model | Core model | Extended model | |||
|---|---|---|---|---|---|---|---|
| aOR (95% CI) | P-value | aOR (95% CI) | P-value | aOR (95% CI) | P-value | ||
| NLR | 0.020 | 0.010 | 0.031 | ||||
| ≤2.88 | 212 | 1.00 | 1.00 | 1.00 | |||
| >2.88 | 131 | 2.38 (1.52–3.75) | <0.001 | 2.48 (1.56–3.95) | <0.001 | 2.49 (1.56–3.98) | <0.001 |
| PLR | 0.001 | <0.001 | 0.006 | ||||
| ≤135.63 | 181 | 1.00 | 1.00 | 1.00 | |||
| >135.63 | 162 | 1.93 (1.24–3.01) | 0.004 | 2.04 (1.29–3.22) | 0.002 | 1.85 (1.16–2.95) | 0.010 |
BMI, body mass index; AJCC, American Joint Committee on Cancer; CI, confidence interval; aOR, adjusted odds ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.
a
Adjusted covariates: basic model: univariate analysis; core model: age, gender, and BMI; extended model: basic model plus hypertension, diabetes, cardiovascular diseases, smoking, surgery type, laterality, AJCC stage, T stage, N stage, M stage, and Fuhrman grade.
Bold values means there is a statistically difference in the result.